AJP - Cell Physiology, Vol 260, Issue 4 C721-C730, Copyright © 1991 by American Physiological Society

ARTICLES

Tyrphostins inhibit PDGF-induced DNA synthesis and associated early events in smooth muscle cells

G. E. Bilder, J. A. Krawiec, K. McVety, A. Gazit, C. Gilon, R. Lyall, A. Zilberstein, A. Levitzki, M. H. Perrone and A. B. Schreiber
Department of Cardiovascular Biology, Rhone-Poulenc Rorer, King of Prussia, Pennsylvania 19406.

Tyrphostins are low-molecular-weight synthetic inhibitors of protein tyrosine kinase, which block cell proliferation. Since platelet-derived growth factor (PDGF) is thought to figure prominently in disorders of vascular smooth muscle cells (VSMC), such as atherosclerosis, hypertension, and restenosis, we examined whether tyrphostins would inhibit PDGF-induced mitogenesis in VSMC. In this communication, we demonstrate that tyrphostins with the benzenemalononitrile nucleus inhibited PDGF-dependent growth of VSMC as well as PDGF-dependent DNA synthesis in these cells, with the concentrations for 50% inhibition ranging from 0.04 to 9 microM. Up to 30-fold higher tyrphostin concentrations were required to inhibit serum-stimulated DNA synthesis of VSMC. The effect of the tyrphostins is reversible, since on their removal a normal proliferative response to PDGF was resumed. Tyrphostins also inhibited PDGF-receptor autophosphorylation and PDGF-induced phosphorylation of intracellular substrates, including the phosphorylation of phospholipase C-gamma, with a potency ratio similar to their antimitogenic activity. The expression of c-fos mRNA, a mitogenic nuclear signal, was also reduced in PDGF-stimulated VSMC treated with tyrphostins at concentrations which inhibit PDGF-induced mitogenesis. It is concluded that tyrphostins are potent reversible inhibitors of PDGF-induced mitogenesis which act by inhibiting the tyrosine kinase activity of the PDGF receptor and the subsequent signaling cascade. Tyrphostins may be useful in the study and treatment of VSMC proliferation disorders.

This article has been cited by other articles:

				H. Han, M. Fuortes, and C. Nathan Critical Role of the Carboxyl Terminus of Proline-rich Tyrosine Kinase (Pyk2) in the Activation of Human Neutrophils by Tumor Necrosis Factor: Separation of Signals for the Respiratory Burst and Degranulation J. Exp. Med., December 18, 2002; (2002) 20021638. [Abstract] [Full Text] [PDF]

				P. K. Carmines, R. W. Fallet, Q. Che, and K. Fujiwara Tyrosine Kinase Involvement in Renal Arteriolar Constrictor Responses to Angiotensin II Hypertension, February 1, 2001; 37(2): 569 - 573. [Abstract] [Full Text] [PDF]

				C. Agus, K. F. Ilett, F. F. Kadlubar, and R. F. Minchin Characterization of an ATP-dependent pathway of activation for the heterocyclic amine carcinogen N-hydroxy-2-amino-3-methylimidazo[4,5-f]quinoline Carcinogenesis, June 1, 2000; 21(6): 1213 - 1219. [Abstract] [Full Text] [PDF]

				R. E. Favoni and A. De Cupis The Role of Polypeptide Growth Factors in Human Carcinomas: New Targets for a Novel Pharmacological Approach Pharmacol. Rev., June 1, 2000; 52(2): 179 - 206. [Abstract] [Full Text] [PDF]

				I. Fishbein, J. Waltenberger, S. Banai, L. Rabinovich, M. Chorny, A. Levitzki, A. Gazit, R. Huber, U. Mayr, S. D. Gertz, et al. Local Delivery of Platelet-Derived Growth Factor Receptor-Specific Tyrphostin Inhibits Neointimal Formation in Rats Arterioscler. Thromb. Vasc. Biol., March 1, 2000; 20(3): 667 - 676. [Abstract] [Full Text] [PDF]

				C. Mineo, G. N. Gill, and R. G. W. Anderson Regulated Migration of Epidermal Growth Factor Receptor from Caveolae J. Biol. Chem., October 22, 1999; 274(43): 30636 - 30643. [Abstract] [Full Text] [PDF]

				H. Ben-Bassat, S. Rosenbaum-Mitrani, Z. Hartzstark, R. Levitzki, M. Chaouat, Z. Shlomai, B. Y. Klein, N. Kleinberger-Doron, A. Gazit, R. Tsvieli, et al. Tyrphostins That Suppress the Growth of Human Papilloma Virus 16-Immortalized Human Keratinocytes J. Pharmacol. Exp. Ther., September 1, 1999; 290(3): 1442 - 1457. [Abstract] [Full Text]

				G. Bilder, T. Wentz, R. Leadley, D. Amin, L. Byan, B. O'Conner, S. Needle, H. Galczenski, J. Bostwick, C. Kasiewski, et al. Restenosis Following Angioplasty in the Swine Coronary Artery Is Inhibited By an Orally Active PDGF-Receptor Tyrosine Kinase Inhibitor, RPR101511A Circulation, June 29, 1999; 99(25): 3292 - 3299. [Abstract] [Full Text] [PDF]

				T. Ogura, L. M. Shuba, and T. F. McDonald L-type Ca2+ current in guinea pig ventricular myocytes treated with modulators of tyrosine phosphorylation Am J Physiol Heart Circ Physiol, May 1, 1999; 276(5): H1724 - H1733. [Abstract] [Full Text] [PDF]

				R. L. Panek, G. H. Lu, T. K. Dahring, B. L. Batley, C. Connolly, J. M. Hamby, and K. J. Brown In Vitro Biological Characterization and Antiangiogenic Effects of PD 166866, a Selective Inhibitor of the FGF-1 Receptor Tyrosine Kinase J. Pharmacol. Exp. Ther., July 1, 1998; 286(1): 569 - 577. [Abstract] [Full Text]

				S. Banai, Y. Wolf, G. Golomb, A. Pearle, J. Waltenberger, I. Fishbein, A. Schneider, A. Gazit, L. Perez, R. Huber, et al. PDGF-Receptor Tyrosine Kinase Blocker AG1295 Selectively Attenuates Smooth Muscle Cell Growth In Vitro and Reduces Neointimal Formation After Balloon Angioplasty in Swine Circulation, May 19, 1998; 97(19): 1960 - 1969. [Abstract] [Full Text] [PDF]

				J. Liu, D. Fitzli, M. Liu, I. Tseu, I. Caniggia, D. Rotin, and M. Post PDGF-induced glycosaminoglycan synthesis is mediated via phosphatidylinositol 3-kinase Am J Physiol Lung Cell Mol Physiol, May 1, 1998; 274(5): L702 - L713. [Abstract] [Full Text] [PDF]

				M. D. Hilborn, R. R. Vaillancourt, and S. G. Rane Growth Factor Receptor Tyrosine Kinases Acutely Regulate Neuronal Sodium Channels through the Src Signaling Pathway J. Neurosci., January 15, 1998; 18(2): 590 - 600. [Abstract] [Full Text] [PDF]

				R. L. Panek, G. H. Lu, S. R. Klutchko, B. L. Batley, T. K. Dahring, J. M. Hamby, H. Hallak, A. M. Doherty, and J. A. Keiser In Vitro Pharmacological Characterization of PD 166285, a New Nanomolar Potent and Broadly Active Protein Tyrosine Kinase Inhibitor J. Pharmacol. Exp. Ther., December 1, 1997; 283(3): 1433 - 1444. [Abstract] [Full Text]

				T. C. Major and J. A. Keiser Inhibition of Cell Growth: Effects of the Tyrosine Kinase Inhibitor CGP 53716 J. Pharmacol. Exp. Ther., October 1, 1997; 283(1): 402 - 410. [Abstract] [Full Text]

				K. A. Tazi, C. Trombino, R. Moreau, and D. Lebrec Responsiveness to growth factors in aortic vascular smooth muscle cells from rats with cirrhosis Am J Physiol Gastrointest Liver Physiol, October 1, 1997; 273(4): G883 - G890. [Abstract] [Full Text] [PDF]

				T. K. Dahring, G. H. Lu, J. M. Hamby, B. L. Batley, A. J. Kraker, and R. L. Panek J. Pharmacol. Exp. Ther., June 1, 1997; 281(3): 1446 - 1456. [Abstract]